November 27, 2022

The Domestikated Life

One Passion

Genome sequencing co Ultima Genomics raises $600m

&#13

Genome sequencing firm Ultima Genomics has occur out of stealth and introduced $600 million in financing. Started in 2016 by its Israeli CEO Gilad Almogy, the organization has 350 staff like 50 in Israel at development centers in Rehovot and Hod Hasharon, and remarkably has managed to reduce any leaks of info from its workforce, investors and growth centers.

&#13

The organization has now exposed that it has produced a sequencing device, which it statements, backed up by investigation set to be revealed in main scientific periodicals, will allow genome sequencing for $100, as opposed with the $500-600 it fees working with its rival Illumina (Nasdaq: ILMN). In addition, Ultima Genomics promises that its genomic sequencing is a lot quicker and deeper – in other text, it supplies far more facts about the genome, extra rapidly.

&#13

The positive aspects of these enhancements, which are allowed as a result of patents that the organization has not however disclosed, are predominantly in two directions. Via this technologies, the company estimates and hopes, it will be achievable to attain genome sequencing even down to single cells, and therefore diagnose ailments even earlier than at current, generally cancer. In addition, sequencing that is more affordable, more quickly and richer in data, will enable a lot a lot quicker progress in assignments that evaluate the genetics of the genuine morbidity of substantial figures of individuals, in order to map the genes included in various ailments.

&#13

Sources at Ultima Genomics say that the rationale for the secrecy above the decades was the want to achieve the position in which the company could establish its solution, prior to building any announcements. The business also preferred not to stir up its rivals, mostly Illumina.

&#13

Ultima Genomics CEO and founder Gilad Almogy is a graduate of the IDF’s Talpiot science and leadership plan. Almogy is nowadays resident in the US. He was a senior vice president at Applied Resources right before founding solar power organization Cogenra Photo voltaic in 2009, which was obtained by SunPower in 2015. In late 2016, Almogy started Ultima.

&#13

Almogy explained, “DNA is nature’s storage media and the instruction set for each individual residing organism, nonetheless with present systems, we can not accessibility that details at the scale needed to actually have an understanding of intricate biology. Our architecture is meant for radical scaling, and the $100 genome is simply the 1st example of what it can supply. We are committed to constantly drive down the price of genomic facts until it is routinely applied in each individual part of the health care system.”

&#13
&#13
&#13
&#13

&#13
&#13
&#13
&#13

Ultima Genomics CSO Doron Lipson included, “Experts and clinicians continually make tradeoffs involving the breadth, depth, and frequency of genomic information and facts they gather. By conquering the restrictions of regular future-generation sequencing technologies, researchers can now style experiments and scientific assays that had been earlier impossible.”

&#13

One particular of the first traders in Ultima Genomics was Israeli billionaire and Test Place founder Marius Nacht, who is also a graduate of the IDF’s Talpiot method. Nqcht founded the aMoon healthtech and everyday living science expense fund, to begin with investing his individual assets just before getting to be an unbiased fund, which in current years elevated a $750 million progress fund. aMoon has also invested in Ultima Genomics.

&#13

Other investors in Ultima Genomics contain D1 Funds, Andreessen Horowitz, Typical Atlantic, Khosla Ventures, Lightspeed, Playground World wide, and Founders Fund.

&#13

Entire disclosure: Marius Nacht is the previous life associate of Anat Agmon, element of the managing shareholders in “Globes.” They are associated in a personal and economic dispute

&#13

Released by Globes, Israel enterprise news – en.globes.co.il – on June 2, 2022.

&#13

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.

&#13
&#13